Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

195
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
195
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

2.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

658
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
658
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

305
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
305
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

869
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
869
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Ironing Out the Details: Advancing Diagnosis and Treatment of Iron Deficiency in Patients with Heart Failure with Preserved Ejection Fraction - A Narrative Review.

Heart failure reviews·2026
Same author

Noninvasive Wearable-Based Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptide Levels.

JACC. Heart failure·2026
Same author

Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance.

Circulation. Population health and outcomes·2026
Same author

Single center automated, multi-source deeply phenotyped heart transplant registry as a template to build tailored data infrastructure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Comparative analysis of randomized versus real-world populations in heart failure: DIAMOND trial vs CARE-HK registry.

ESC heart failure·2026
Same author

Alerts Are Not Treatment: ALLEVIATE-HF and the Execution Gap in Heart Failure.

Journal of the American College of Cardiology·2026

相关实验视频

Updated: Jan 7, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.3K

在急性心力衰竭中通过心前系统机械降低心脏预负荷.

Rayan Yousefzai1, Arvind Bhimaraj2, Michael S Kiernan3

  • 1DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA. Electronic address: https://twitter.com/RAYANYOUX.

JACC. Heart failure
|December 13, 2025
PubMed
概括

在治疗急性不补偿性心力衰竭 (ADHF) 中,preCARDIA系统证明了安全性和可行性. 这种新型装置降低了心脏填充压力,并增加了患者的尿液输出,为进一步的临床试验铺平了道路.

关键词:
急性不补偿性心力衰竭是什么心脏预负载的预负载拥堵 拥堵 拥堵医疗器械治疗的设备治疗

更多相关视频

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.9K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K

相关实验视频

Last Updated: Jan 7, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.3K
Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.9K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K

科学领域:

  • 心血管医学 心血管医学
  • 医疗器械 医疗器械
  • 心脏衰竭研究研究

背景情况:

  • 急性不补偿性心力衰竭 (ADHF) 是一种危急的疾病,通常需要进行干预,以控制心脏填充压力的升高.
  • 预卡迪亚装置提供了一种新的方法,通过调节上 vena cava 血流来机械降低这些压力.

研究的目的:

  • 评估下一代前心脏系统在ADHF患者中的安全性和可行性.
  • 在VENUS-HF早期可行性研究 (NCT03836079) 中,评估了更新的preCARDIA系统,包括外套,导管和控制台的修改.

主要方法:

  • 一项多中心,前性,单臂研究招募了60名ADHF患者.
  • 试验对象接受了长达24小时的心脏前支持,安全性和技术可行性是主要终点.

主要成果:

  • 预卡迪亚系统的安全性很高,没有98.3%的重大不良事件,部署/移除100%成功.
  • 观察到右心房压力 (23%) 和肺毛细血管压力 (18%) 的显著降低.
  • 与治疗前期相比,在24小时使用设备期间,净尿量增加了1.9升.

结论:

  • 前心脏系统是对ADHF的可行和耐受性良好的干预措施.
  • 早期的结果表明,心脏填充压力显著降低,尿液输出改善.
  • 这些发现支持大型试验,如COR-ADHF试验,以确认临床疗效.